{
  "title": "Efficacy and safety of anti-PD-1/PD-L1 antibodies in patients with relapsed refractory diffuse large B-cell lymphoma: A meta-analysis.",
  "pmid": "40771412",
  "doi": null,
  "affiliations": [
    "Clinical Medicine School, Shandong Second Medical University, No. 4948, Victory East Street, Weifang, Shandong, 261000, China.",
    "Qilu Hospital of Shandong University, Dezhou Hospital, No. 1 Shangde Sixth Road, Decheng District, Dezhou, Shandong, 253000, China.",
    "Department of Medical Imaging, Shengli Oilfield Central Hospital, No. 31, Jinan Road, Dongying District, Dongying, Shandong, 257034, China.",
    "Department of Hematology, Shengli Oilfield Central Hospital, No. 31, Jinan Road, Dongying District, Dongying, Shandong, 257034, China.",
    "Department of Hematology, Shengli Oilfield Central Hospital, No. 31, Jinan Road, Dongying District, Dongying, Shandong, 257034, China.",
    "Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong, Academy of Medical Sciences, No. 440, Jiyan Highway, Huaiyin District, Jinan, Shandong, 250117, China.",
    "Department of Hematology, Shengli Oilfield Central Hospital, No. 31, Jinan Road, Dongying District, Dongying, Shandong, 257034, China."
  ]
}